LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
Background. Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies worldwide. It is characterized by its high invasive and metastatic potential. Leprecan-like 1 (LEPREL1) has been demonstrated to be downregulated in the HCC tissues in previous proteomics studies. The present stud...
Main Authors: | Wang, Jianguo, Xu, Xiao, Liu, Zhikun, Wei, Xuyong, Zhuang, Runzhou, Lu, Di, Zhou, Lin, Xie, Haiyang, Zheng, Shusen |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844253/ |
Similar Items
-
Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis
by: Xu, Xiao, et al.
Published: (2015) -
Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
by: LIU, ZHIKUN, et al.
Published: (2013) -
Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma
by: Xu, Xiao, et al.
Published: (2016) -
miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats
by: Xu, Xiao, et al.
Published: (2016) -
Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
by: Yan, Yingcai, et al.
Published: (2016)